Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.

Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR.

Clin Infect Dis. 2009 Mar 1;48(5):642-9. doi: 10.1086/597007.

2.

Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.

de Lastours V, LeGoff J, Brière J, Agbalika F, Boulet T, Lévy Y, Simon F, Aboulker JP, Molina JM.

HIV Med. 2014 Jan;15(1):23-9. doi: 10.1111/hiv.12077. Epub 2013 Sep 6.

3.

Epstein-Barr viral load as a marker of lymphoma in AIDS patients.

Fan H, Kim SC, Chima CO, Israel BF, Lawless KM, Eagan PA, Elmore S, Moore DT, Schichman SA, Swinnen LJ, Gulley ML.

J Med Virol. 2005 Jan;75(1):59-69.

PMID:
15543571
4.

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.

Bossolasco S, Cinque P, Ponzoni M, Vigano MG, Lazzarin A, Linde A, Falk KI.

J Neurovirol. 2002 Oct;8(5):432-8.

PMID:
12402169
5.

Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.

Spacek M, Hubacek P, Markova J, Zajac M, Vernerova Z, Kamaradova K, Stuchly J, Kozak T.

APMIS. 2011 Jan;119(1):10-6. doi: 10.1111/j.1600-0463.2010.02685.x. Epub 2010 Oct 25.

PMID:
21143522
6.

Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.

Kabyemera R, Masalu N, Rambau P, Kamugisha E, Kidenya B, De Rossi A, Petrara MR, Mwizamuholya D.

BMC Pediatr. 2013 Jan 7;13:4. doi: 10.1186/1471-2431-13-4.

7.

A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.

Bonnet F, Jouvencel AC, Parrens M, Leon MJ, Cotto E, Garrigue I, Morlat P, Beylot J, Fleury H, Lafon ME.

J Clin Virol. 2006 Aug;36(4):258-63. Epub 2006 Jun 9.

PMID:
16762591
8.

Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.

Bossolasco S, Falk KI, Ponzoni M, Ceserani N, Crippa F, Lazzarin A, Linde A, Cinque P.

Clin Infect Dis. 2006 Feb 15;42(4):e21-5. Epub 2006 Jan 11.

9.

Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.

Leong IT, Fernandes BJ, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93.

PMID:
11505266
10.

Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.

Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E.

J Med Virol. 2005 Jan;75(1):54-8.

PMID:
15543583
11.

Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma.

Pajand O, Pourakbari B, Mahjob F, Aghamohammadi A, Mamishi N, Mamishi S.

Pediatr Hematol Oncol. 2011 Feb;28(1):10-5. doi: 10.3109/08880018.2010.507691. Epub 2010 Nov 17.

PMID:
21083364
12.

Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.

Jo SA, Hwang SH, Kim SY, Shin HJ, Chung JS, Sol MY, Chang CL, Lee EY.

Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e106-13. doi: 10.1111/j.1751-553X.2009.01171.x. Epub 2009 Jun 12.

PMID:
19522857
13.

Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.

Dehee A, Asselot C, Piolot T, Jacomet C, Rozenbaum W, Vidaud M, Garbarg-Chenon A, Nicolas JC.

J Med Virol. 2001 Nov;65(3):543-52.

PMID:
11596092
14.

Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.

Gill H, Hwang YY, Chan TS, Pang AW, Leung AY, Tse E, Kwong YL.

J Clin Virol. 2014 Apr;59(4):255-8. doi: 10.1016/j.jcv.2014.01.005. Epub 2014 Jan 18.

PMID:
24507802
15.

Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.

Carbone A, Dolcetti R, Gloghini A, Maestro R, Vaccher E, di Luca D, Tirelli U, Boiocchi M.

Hum Pathol. 1996 Feb;27(2):133-46.

PMID:
8617454
16.

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Gandhi MK, Lambley E, Burrows J, Dua U, Elliott S, Shaw PJ, Prince HM, Wolf M, Clarke K, Underhill C, Mills T, Mollee P, Gill D, Marlton P, Seymour JF, Khanna R.

Clin Cancer Res. 2006 Jan 15;12(2):460-4.

17.

Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.

O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD.

J Med Virol. 2002 Jul;67(3):320-6.

PMID:
12116021
18.

Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.

Machado AS, Da Silva Robaina MC, Magalhães De Rezende LM, Apa AG, Amoêdo ND, Bacchi CE, Klumb CE.

Leuk Lymphoma. 2010 Jun;51(6):1020-7. doi: 10.3109/10428191003746331.

PMID:
20470219
19.

High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.

Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM.

AIDS. 2002 May 3;16(7):993-1001.

PMID:
11953465
20.

Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial.

Suleiman J, Zingman BS, Diaz RS, Madruga JV, DeJesus E, Slim J, Mak C, Lee E, McCarthy MC, Dunkle LM, Walmsley S.

J Infect Dis. 2010 Feb 15;201(4):590-9. doi: 10.1086/650342.

Items per page

Supplemental Content

Write to the Help Desk